Studies reviewing lycopene and the incidence of breast cancer

 

Breast cancer is the most common cancer and cause of death from cancer in women throughout the world. Most people know that diets high in fruits and vegetables probably reduce the risk of developing cancer, but now studies indicate that high consumption of tomatoes and tomato products also reduces the risk of developing breast cancer. The reason? Lycopene, an antioxidant that inhibits tumors and is more easily absorbed by the body when tomatoes are processed into juice, sauce and paste.

There are three different sets of evidence for the protective role of lycopene in breast cancer: a) cell culture studies, b) animal studies, and c) epidemiological studies.

In cell culture studies, lycopene's activities in inhibiting breast cancer tumors were compared with those of alpha and beta-carotene(1). The cell cultures that were enhanced with lycopene showed that it inhibited the growth of breast cancer cells (MCF-7), and that alpha and beta-carotene were far less effective than lycopene in inhibiting the cell growth. When lycopene was fed to mice genetically susceptible to developing breast tumors(2), it was found that lycopene-fed mice had suppressed and delayed tumors. Another study(3) showed that rats injected with lycopene developed fewer and smaller size carcinogen-induced tumors than rats without lycopene injections. Beta-carotene didn't provide any protection against breast tumors in this study.

Several studies have showed insignificant or no association between either lycopene from the diet(4) and concentrated lycopene(5) and breast cancer risk, however others have found a relationship between breast tissue lycopene and breast cancer risk(6). A recent study of samples(7) taken from The Breast Cancer Serum Bank in Columbia, Missouri were analyzed to evaluate the relationship of levels of carotenoids (including lycopene), selenium and retinol with breast cancer. Only lycopene was found to reduce the risk for developing breast cancer. Other carotenoids were not found to be associated with reduced breast cancer risk, however long-term studies are needed to establish the protective role of lycopene in breast cancer.

References

  1. Levy J, Bosin E, Feldman B, Giat Y, Miinster, Danilenko M, Sharoni Y. Lycopene is more potent inhibitor of human cancer cell proliferation than either A–carotene or beta–carotene. Nutr Cancer 1995; 24:257-266
  2. Nagasawa H, Mitamura T, Sakamoto S, Yamamoto K. Effects of lycopene on spontaneous mammary tumor development in SHN virgin mice. Anticancer Res 1995; 15:1173-1178
  3. Sharoni Y, Giron E, Rise M, Levy J. Effects of lycopene-enriched tomato oleoresin on 7, 12-dimethyl-benz(a)anthracene-induced rat mammary tumors. Cancer Detect Preven 1997; 21:118-123
  4. Freudenheim JL, Marshall JR, Vena JE, Laughlin R, Brasure JR, Swanson MK, Nemoto T, Graham S. Premenopausal breast cancer risk and intake of vegetables, fruits and related nutrients. J Natl Cancer Inst 1996; 88:340-348
  5. London SJ, Stein EA, Henderson IC, Stampfer MJ, Wood WC, Remine S, Dmochowski JR, Robert NJ, Willett WC. Carotenoids, retinol and vitamin e and risk of proliferative benign breast disease and breast cancer. Cancer Causes Control 1992; 3:503-512
  6. Zhang S, Tang G, Russell RM, Mayzel KA, Stampfer MJ, Willett WC, Hunter DJ. Measurement of retinoids and carotenoids in breast adipose tissue and a comparison of concentrations in breast cancer cases and control subjects. Am J Clin Nutru 1997; 66:626-632
  7. Dorgan JF, Sowell A, Swanson CA, Potischman N, Miller R, Schussler N, Stephenson HEJr. Relationships of serum carotenoids, retinol, a-tocorpherol and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control 1998; 9:89-97